Tirzepatide API
Product Overview
Tirzepatide is a synthetic peptide Active Pharmaceutical Ingredient (API) with dual activity on glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.
This material is supplied exclusively for pharmaceutical research, development, and manufacturing applications.
⸻
Mechanism of Action (Scientific Background)
Tirzepatide interacts with GIP and GLP-1 receptor pathways, which are extensively studied in metabolic and endocrinology research models.
Its dual receptor activity has made it a compound of interest in preclinical research, formulation development, and process optimization studies.
⸻
Product Category
•Peptide Active Pharmaceutical Ingredient (API)
⸻
Intended Use
•Pharmaceutical research and development
•Analytical reference standard
•Process development and scale-up studies
•Formulation and stability studies
⸻
Quality & Manufacturing
•Manufactured under controlled conditions suitable for pharmaceutical development
•Comprehensive documentation available upon request
•Batch-specific Certificate of Analysis (CoA) provided
⸻
Packaging
Supplied in bulk API form for industrial and research applications.
(Custom packaging options available upon request.)
⸻
Important Disclaimer
⚠️ For research, analytical, and manufacturing purposes only.
⚠️ Not a finished pharmaceutical product.
⚠️ Not for human or veterinary use.
⚠️ Not intended for diagnosis, treatment, or prevention of any disease.
⸻
Regulatory Notice
Parsian Pharma does not market, distribute, or sell finished dosage forms and does not offer products for individual or patient use.
All products are supplied strictly on a B2B basis to licensed pharmaceutical companies, research institutions, and manufacturing partners.
